BPC-157 tackles this problem directly by: Stimulating neoangiogenesis within the tendon or ligament substance Activating tenocytes (tendon cells) to produce organized collagen Reducing fibrotic adhesion formation that limits range of motion Condition-by-Condition Clinical Applications Tendinopathies Chronic tendon conditionsAchilles, patellar, rotator cuff, lateral epicondyle (tennis elbow), medial epicondyle (golfers elbow)respond exceptionally well to BPC-157
Lab-Tested for Quality and Consistency Tested every 3 to 6 months to confirm that the active ingredient falls within 10% of its intended concentration
Key Points: It is a derivative of the amino acid cysteine, and is called N-Acetyl-L-Cysteine or Mucomyst
This means clinical studies have shown the procedure works, and is safe
Apart from being an important skin-identical ingredient, it's also an emollient and stabilizer
These findings demonstrate DOPs protective role through modulation of the gut-liver axis (139)